These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
98 related articles for article (PubMed ID: 6600288)
1. Myoclonus, ataxia, and hypoventilation: response to L-5-hydroxytryptophan. Feit H; Kirkpatrick J; Van Woert MH; Pandian G Neurology; 1983 Jan; 33(1):109-12. PubMed ID: 6600288 [No Abstract] [Full Text] [Related]
2. L-5-hydroxytryptophan in treatment of several different syndromes in which myoclonus is prominent. Growdon JH; Young RR; Shahani BT Neurology; 1976 Dec; 26(12):1135-40. PubMed ID: 1086988 [TBL] [Abstract][Full Text] [Related]
6. [Case of intention myoclonus (Lance-Adams syndrome) and a dramatic effect of L-5-hydroxytryptophan]. Satoyoshi E; Kinoshita M; Takazawa Y; Yoda K Rinsho Shinkeigaku; 1976 Sep; 16(9):654-60. PubMed ID: 1087598 [No Abstract] [Full Text] [Related]
7. L-5-hydroxytryptophan therapy in myoclonus. Van Woert MH; Rosenbaum D Adv Neurol; 1979; 26():107-15. PubMed ID: 316273 [No Abstract] [Full Text] [Related]
8. Palatal myoclonus treated with 5-hydroxytryptophan and a decarboxylase-inhibitor. Magnussen I; Dupont E; Prange-Hansen A; de Fine Olivarius B Acta Neurol Scand; 1977 Mar; 55(3):251-53. PubMed ID: 300537 [No Abstract] [Full Text] [Related]
9. [Utilization of levo-5-hydroxytryptophan in post-anoxic myoclonus]. Rascol A; Guiraud-Chaumeil B; Laboucarie J; Montastruc JL; El-Hage W Therapie; 1978; 33(5):623-8. PubMed ID: 311085 [No Abstract] [Full Text] [Related]
10. Improvement of action myoclonus by an administration of 5-hydroxytryptophan and carbidopa in a child with muscular subsarcolemmal hyperactivity. Nakano K; Hayakawa T; Shishikura K; Ohsawa M; Suzuki H; Fukuyama Y Brain Dev; 1990; 12(5):516-20. PubMed ID: 2288384 [TBL] [Abstract][Full Text] [Related]
11. Successful treatment of cherry red spot-myoclonus syndrome with 5-hydroxytryptophan. Gascon G; Wallenberg B; Daif AK; Ozand P Ann Neurol; 1988 Sep; 24(3):453-5. PubMed ID: 3265864 [TBL] [Abstract][Full Text] [Related]
12. Letter: Relief of action myoclonus by 5-hydroxytryptophan. Chadwick D; Reynolds EH; Marsden CD Lancet; 1974 Jul; 2(7872):111-2. PubMed ID: 4136988 [No Abstract] [Full Text] [Related]
13. Myoclonus. Marsden CD Mod Trends Neurol; 1975; 6():321-2. PubMed ID: 1105145 [No Abstract] [Full Text] [Related]
14. Post-hypoxic intention myoclonus treated with 5-hydroxy-tryptophan and an extracerebral decarboxylase inhibitor. Magnussen I; Dupont E; Engbaek F; de Fine Olivarius B Acta Neurol Scand; 1978 Apr; 57(4):289-94. PubMed ID: 307327 [TBL] [Abstract][Full Text] [Related]
15. Clinical and metabolic observations on the treatment of myoclonus with L-5-HTP and carbidopa. Thal L; Sharpless N; Wolfson L; Engel J; Katzman R Trans Am Neurol Assoc; 1976; 101():48-52. PubMed ID: 1088459 [No Abstract] [Full Text] [Related]
16. Functional independence in post-anoxic myoclonus: contribution of L-5-HTP sodium valproate and clonazepam. Carroll WM; Walsh PJ Br Med J; 1978 Dec; 2(6152):1612. PubMed ID: 365292 [No Abstract] [Full Text] [Related]
17. [Letter: Combination of a dopa decarboxylase inhibitor with 5-hydroxytryptophan therapy]. Lhermitte F; Degos CF; Marteau R Nouv Presse Med; 1975 Jan; 4(1):31. PubMed ID: 1079935 [No Abstract] [Full Text] [Related]
18. From the NIH: New treatment for myoclonus patients. JAMA; 1980 May; 243(17):1705-6. PubMed ID: 6965990 [No Abstract] [Full Text] [Related]
19. Long-term therapy of myoclonus and other neurologic disorders with L-5-hydroxytryptophan and carbidopa. Van Woert MH; Rosenbaum D; Howieson J; Bowers MB N Engl J Med; 1977 Jan; 296(2):70-5. PubMed ID: 401457 [TBL] [Abstract][Full Text] [Related]
20. L-5 HTP available under treatment IND. FDA Drug Bull; 1983 Aug; 13(2):12-3. PubMed ID: 6604672 [No Abstract] [Full Text] [Related] [Next] [New Search]